Predicate |
Object |
contentType |
Journal Article|Review |
endingPage |
52 |
issn |
1387-2877 1875-8908 |
issueIdentifier |
s2 |
pageRange |
43-52 |
publicationName |
Journal of Alzheimer's disease : JAD |
startingPage |
43 |
bibliographicCitation |
Townsend M. When will Alzheimer's disease be cured? A pharmaceutical perspective. J Alzheimers Dis. 2011;24 Suppl 2():43–52. doi: 10.3233/jad-2011-110020. PMID: 21368375. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3687990a10fcb50ff11f1adedff81a37 |
date |
2011-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://pubmed.ncbi.nlm.nih.gov/21368375 https://doi.org/10.3233/jad-2011-110020 |
isPartOf |
https://portal.issn.org/resource/ISSN/1875-8908 https://portal.issn.org/resource/ISSN/1387-2877 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21942 |
language |
English |
source |
https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/ |
title |
When Will Alzheimer's Disease be Cured? A Pharmaceutical Perspective |
discusses |
http://id.nlm.nih.gov/mesh/M0021770 |
hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D000544Q000188 http://id.nlm.nih.gov/mesh/D004345Q000639 http://id.nlm.nih.gov/mesh/D014150Q000627 |
hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D017326Q000639 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D017326Q000379 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D004345Q000379 |